← Back to Search

Successful aging health education intervention for Cognitive Decline (ACHIEVE Trial)

N/A
Waitlist Available
Led By Josef Coresh
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 year
Awards & highlights

ACHIEVE Trial Summary

This trial will test if a hearing intervention can help 70-84 year-olds with hearing loss stay cognitively normal.

Eligible Conditions
  • Cognitive Decline
  • Aging

ACHIEVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Global Cognitive Function
Secondary outcome measures
Change in Cognition Executive Function Domain
Change in Cognition Language Domain
Change in Cognition Memory Domain
+1 more
Other outcome measures
3-year Global Cognitive Change Restricted to ARIC Participants
3-year Global Cognitive Change Restricted to De Novo Participants
Depressive Symptoms
+12 more

ACHIEVE Trial Design

2Treatment groups
Active Control
Group I: Successful aging health education interventionActive Control1 Intervention
Individual sessions on healthy aging topics
Group II: Hearing interventionActive Control1 Intervention
Best practices hearing rehabilitative treatment

Find a Location

Who is running the clinical trial?

University of North CarolinaOTHER
168 Previous Clinical Trials
1,449,345 Total Patients Enrolled
1 Trials studying Cognitive Decline
859 Patients Enrolled for Cognitive Decline
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
410 Previous Clinical Trials
2,105,953 Total Patients Enrolled
Wake Forest UniversityOTHER
190 Previous Clinical Trials
163,623 Total Patients Enrolled
3 Trials studying Cognitive Decline
2,075 Patients Enrolled for Cognitive Decline

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research accommodating individuals aged sixty and over?

"The selection criteria for this trial stipulates the minimum age of enrolment as 70 years old and a maximum age of 84."

Answered by AI

How many venues are currently conducting this clinical experiment?

"Four locations are currently offering this study: Wake Forest University in Winston-Salem, the University of Minnesota in Minneapolis, and Mississippi Medical Center in Jackson; with additional sites located throughout the country."

Answered by AI

Are there any remaining vacancies for participants in this investigation?

"This clinical trial is not taking new patients. It was first posted on April 1st, 2018 and the last update occurred August 10th, 2022. Despite this study no longer recruiting candidates, there are currently 789 other trials that have open enrolment."

Answered by AI

Is it possible for me to join this clinical experiment?

"Participants accepted into this trial must demonstrate cognitive impairment and be between 70-84 years of age. Currently, 977 individuals are enrolled in the study."

Answered by AI
Recent research and studies
Alzheimer's & Dementia: Translational Research & Clinical InterventionsJournal
Hearing Treatment for Reducing Cognitive Decline: Design and Methods of the Aging and Cognitive Health Evaluation in Elders Randomized Controlled Trial
Deal, Jennifer A., Adele M. Goman, Marilyn S. Albert, Michelle L. Arnold, Sheila Burgard, Theresa Chisolm, David Couper, et al.. 2018. “Hearing Treatment for Reducing Cognitive Decline: Design and Methods of the Aging and Cognitive Health Evaluation in Elders Randomized Controlled Trial”. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Wiley. doi:10.1016/j.trci.2018.08.007.
Ear & HearingJournal
The Hearing Intervention for the Aging and Cognitive Health Evaluation in Elders Randomized Control Trial: Manualization and Feasibility Study
Sanchez, Victoria A., Michelle L. Arnold, Nicholas S. Reed, Preyanca H. Oree, Courtney R. Matthews, Ann Clock Eddins, Frank R. Lin, and Theresa H. Chisolm. 2020. “The Hearing Intervention for the Aging and Cognitive Health Evaluation in Elders Randomized Control Trial: Manualization and Feasibility Study”. Ear & Hearing. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/aud.0000000000000858.
Alzheimer's & Dementia: Translational Research & Clinical InterventionsJournal
Hearing Treatment for Reducing Cognitive Decline: Design and Methods of the Aging and Cognitive Health Evaluation in Elders Randomized Controlled Trial
Deal, Jennifer A., Adele M. Goman, Marilyn S. Albert, Michelle L. Arnold, Sheila Burgard, Theresa Chisolm, David Couper, et al.. 2018. “Hearing Treatment for Reducing Cognitive Decline: Design and Methods of the Aging and Cognitive Health Evaluation in Elders Randomized Controlled Trial”. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Wiley. doi:10.1016/j.trci.2018.08.007.
clinicaltrials.govStudy
Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
2018. "Aging and Cognitive Health Evaluation in Elders (ACHIEVE)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03243422.
~133 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top